)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Intensity Therapeutics (INTS) investor relations material
Intensity Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary7 Aug, 2025
Executive summary
Over $11 million raised since Q2 2025, extending cash runway into the second half of 2026.
Net loss for the six months ended June 30, 2025 was $5.9 million; Q2 2025 net loss was $2.5 million, down from $5.0 million in Q2 2024.
Focused on late-stage clinical development of INT230-6 for cancer, with ongoing Phase 3 and Phase 2 trials in sarcoma and breast cancer.
No revenue generated to date; operations funded primarily through equity and debt offerings.
Collaboration formed to raise patient awareness for early-stage disease treatment options.
Financial highlights
Research and development expenses decreased 42% year-over-year to $3.7 million for the six months ended June 30, 2025; Q2 2025 R&D expenses were $1.5 million, down from $3.6 million in Q2 2024.
General and administrative expenses decreased 31% year-over-year to $2.4 million for the six months ended June 30, 2025; Q2 2025 G&A expenses were $1.2 million, down from $1.5 million.
Net loss per share was $0.13 in Q2 2025, compared to $0.36 in Q2 2024.
Cash and cash equivalents were $2.2 million as of June 30, 2025.
No revenue recognized; no product sales or licensing income expected in the near term.
Outlook and guidance
Cash runway projected into the second half of 2026, assuming no significant changes in operations.
Additional capital will be required to complete clinical trials and support ongoing operations.
Plans to restart paused Phase 3/INVINCIBLE-3 sarcoma trial and complete Phase 2/INVINCIBLE-4 breast cancer trial contingent on funding.
Pathology data from the INVINCIBLE-4 Study expected in the second half of 2026.
INVINCIBLE-3 study restart conditions
Post-2026 cash runway extension plans
INVINCIBLE-4 pathology data implications
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Intensity Therapeutics earnings date
AGM 202522 Oct, 2025
Next Intensity Therapeutics earnings date
AGM 202522 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Intensity Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of cancer immunotherapies. The company's lead platform is designed to deliver therapeutic agents directly into tumors to stimulate immune activation and systemic anti-cancer effects. Its development activities span preclinical research through clinical trials targeting various solid tumors. Intensity Therapeutics Inc is headquartered in Westport, Connecticut, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage